- Report
- July 2023
- 179 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- July 2023
- 80 Pages
Global
From €4215EUR$4,850USD£3,668GBP
- Report
- June 2023
- 22 Pages
Global
€10646EUR$12,250USD£9,266GBP
- Report
- April 2023
- 110 Pages
Global
From €4128EUR$4,750USD£3,593GBP
- Report
- February 2023
- 27 Pages
Global
€10646EUR$12,250USD£9,266GBP
- Report
- January 2023
- 31 Pages
Global
€10646EUR$12,250USD£9,266GBP
- Report
- January 2023
- 27 Pages
Global
€10646EUR$12,250USD£9,266GBP
- Report
- November 2022
- 220 Pages
Global
From €2998EUR$3,450USD£2,610GBP
- Report
- September 2022
- 40 Pages
Global
- Report
- July 2022
- 40 Pages
China
From €2781EUR$3,200USD£2,420GBP
- Report
- April 2021
China
From €2260EUR$2,600USD£1,967GBP
- Report
- April 2018
United States
From €6948EUR$7,995USD£6,047GBP
- Training
- 180 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- December 2022
- 67 Pages
Global
From €3042EUR$3,500USD£2,647GBP
- Report
- September 2025
- 96 Pages
Global
From €3500EUR$4,314USD£3,153GBP
- Report
- August 2024
- 112 Pages
Global
From €3500EUR$4,314USD£3,153GBP
- Report
- February 2024
- 100 Pages
Global
From €3500EUR$4,314USD£3,153GBP
- Report
- October 2023
- 106 Pages
Global
From €3500EUR$4,314USD£3,153GBP
- Report
- June 2023
- 112 Pages
Global
From €3500EUR$4,314USD£3,153GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more